Feng Ping, Wang Bei, Ren Ee Chee
Laboratory of Cell and Medical Biology, Genome Institute of Singapore, 60 Biopolis Street, #02-01, Genome, 138672, Singapore.
Int J Biochem Cell Biol. 2008;40(1):98-109. doi: 10.1016/j.biocel.2007.06.020. Epub 2007 Jul 26.
Cyr61/CCN1 is a secreted extracellular matrix associated protein involved in diverse biological functions and plays multiple roles in tumorigenesis. Cyr61 was down-regulated in HCC tumor tissues as observed in our previous cDNA microarray study, but its potential role in hepatocarcinogenesis is still unclear. To explore the biological significance of Cyr61 in HCC development, over-expression of this gene was established in HCC cell lines and its effects on cell proliferation, adhesion, migration and invasion were analyzed in this study. Cyr61 expression was down-regulated in HCC tumors as measured by quantitative real-time PCR and its protein level was decreased in most HCC cell lines as detected by Western blot. Over-expression of Cyr61 in HCC cell lines suppressed cell proliferation in monolayer and anchorage-independent growth in soft agar, whereas down-regulation of Cyr61 by siRNA increased cell proliferation rate. Over-expression of Cyr61 also significantly enhanced adhesion activities of HepG2 cells to various ECM proteins. Moreover, stably transfected HepG2-Cyr61 cells showed inhibited cell mobility (40-45%) and reduced invasiveness (30-40%) compared to HepG2-Neo controls. Furthermore, upon exposure to 5-Fluorouracil and UV irradiation, Cyr61 was rapidly induced in both p53(+/+) HepG2 and p53(-/-) Hep3B cells. However, only HepG2 cells showed increased G2/M phase arrest with concomitant up-regulation in p53 and p21 levels, suggesting that Cyr61 may play an active role in regulating HCC cell growth involving p53 as well as alternative pathways. In conclusion, we demonstrated that Cyr61 is a tumor suppressor in hepatocarcinogenesis and is involved in DNA damage response.
Cyr61/CCN1是一种分泌型细胞外基质相关蛋白,参与多种生物学功能,并在肿瘤发生中发挥多种作用。正如我们之前的cDNA微阵列研究中所观察到的,Cyr61在肝癌肿瘤组织中表达下调,但其在肝癌发生中的潜在作用仍不清楚。为了探究Cyr61在肝癌发展中的生物学意义,本研究在肝癌细胞系中建立了该基因的过表达,并分析了其对细胞增殖、黏附、迁移和侵袭的影响。通过定量实时PCR检测发现,肝癌肿瘤中Cyr61表达下调,通过蛋白质免疫印迹检测发现,大多数肝癌细胞系中其蛋白水平降低。在肝癌细胞系中过表达Cyr61可抑制单层细胞增殖和软琼脂中不依赖贴壁的生长,而通过小干扰RNA下调Cyr61则可提高细胞增殖率。Cyr61的过表达还显著增强了HepG2细胞对各种细胞外基质蛋白的黏附活性。此外,与HepG2-Neo对照相比,稳定转染的HepG2-Cyr61细胞显示出细胞迁移能力受到抑制(40 - 45%),侵袭性降低(30 - 40%)。此外,在暴露于5-氟尿嘧啶和紫外线照射后,p53(+/+)的HepG2细胞和p53(-/-)的Hep3B细胞中Cyr61均被快速诱导。然而,只有HepG2细胞显示出G2/M期阻滞增加,同时p53和p21水平上调,这表明Cyr61可能在涉及p53以及其他替代途径的肝癌细胞生长调节中发挥积极作用。总之,我们证明了Cyr61是肝癌发生中的一种肿瘤抑制因子,并参与DNA损伤反应。